FDA Approves Frontline Immunotherapy for Gastric Cancers
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Home ยป
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older …
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Yes, the vaccines already authorized for emergency use against …